Sign up to save your podcasts
Or
Share The Tape
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Tape
The Tape episodes
- Kudla on the Fed and BOJ (Audio)(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. \u0010 \u0010GUEST: \u0010David Kudla \u0010CEO/Chief Invsmt Strategist \u0010Mainstay Capital Management LLC \u0010Will discuss analysis of how the Fed, BOJ, and central bank are affecting the stock market.Learn more about your ad-choices at https://www.iheartpodcastnetwork.com8 min
- Moriarity on ETFS and Bitcoin (Audio)(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. \u0010 \u0010GUEST: \u0010Kathleen Moriarity \u0010Partner \u0010Kayle Scholer \u0010Will discuss the regulation of ETFs and Bitcoin at the BNY Mellon ETF Symposium.Learn more about your ad-choices at https://www.iheartpodcastnetwork.com12 min
- Kirwan on Smart Beta ETFs (Audio)(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. \u0010 \u0010GUEST: \u0010Kieran Kirwan \u0010Senior Investment Strategist \u0010ProShares \u0010Will discuss how Smart Beta ETFs have been highlighted as a primary driver of future growth in the ETF industry at the BNY Mellon ETF Symposium.Learn more about your ad-choices at https://www.iheartpodcastnetwork.com8 min
- LaSalla on Adding Allocations to Alternatives (Audio)(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. \u0010 \u0010GUEST: \u0010Frank Lasalla \u0010Managing Director \u0010Bank of New York Mellon Corp The \u0010Will discuss why investors are continuing to add allocations to alternatives at the BNY Mellon ETF Symposium.\u0010\u0010\u0010\u0010\u0010\u0010\u0010\u0010\u0010\u0010\u0010\u0010\u0010\u0010\u0010\u0010\u0010\u0010Will discuss why investors are continuing to add allocations to alternatives at the BNY ETF Symposium.Learn more about your ad-choices at https://www.iheartpodcastnetwork.com12 min
- Timblerlake on V-GO Insulin Delivery Device (Correct) (Audio)(Bloomberg) -- Corrects description for V-GO\u0010\u0010Taking Stock with Kathleen Hays and Pimm Fox.\u0010\u0010GUEST: John Timberlake on getting FDA approval for the V-GO, the only wearable, fully disposable insulin delivery device in the world.Learn more about your ad-choices at https://www.iheartpodcastnetwork.com8 min
- Vinnie Schoenfelder on Keeping Companies Safe (Audio)(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.\u0010\u0010GUEST:\u0010Vinnie Schoenfelder on the digital transformation of the company, and also how it is representing government, banks, and big businesses in the face of security hacks.Learn more about your ad-choices at https://www.iheartpodcastnetwork.com8 min
- Shep Gordon on Being a `Supermensch' (Audio)(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.\u0010\u0010GUEST:\u0010Shep Gordon on his new book:"THEY CALL ME SUPERMENSCH: A Backstage Pass to the Amazing Worlds of Film, Food, and Rock’n’Roll."Learn more about your ad-choices at https://www.iheartpodcastnetwork.com8 min
- Melissa Brown on Smart Beta ETFs (Audio)(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.GUEST:Melissa Brown, Senior Director of Applied Research at Axioma, on their "buyer beware" research on smart beta ETFs.Learn more about your ad-choices at https://www.iheartpodcastnetwork.com10 min
- Ciocca on Relationship Between D.C. and Wall Street (Audio)(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.GUEST:Doug Ciocca CEO and Partner of Kavar Capital, on markets, investments and the tightrope between Washington and Wall Street.Learn more about your ad-choices at https://www.iheartpodcastnetwork.com13 min
- Jan Ryde from Hästens on High End Mattresses (Audio)(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.GUEST:Jan Ryde, owner of Hästens, on why you should invest in a $100k mattress.Learn more about your ad-choices at https://www.iheartpodcastnetwork.com13 min
About The Tape
From the publisher's feed
Matt Miller and Paul Sweeney focus on market coverage as Wall Street begins its day, with analysis from Bloomberg Opinion writers, Bloomberg Intelligence analysts, and influential newsmakers.